GlassScriptPhysician profile
Eugene V Mayeaux
NPI 1780685966
$631.75
in general payments reported to CMS, 2019-2025
11 companies · $82.41 in 2025
The $82.41 reported for 2025 was more than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2022: $94.23 · 2023: $220 · 2024: $108 · 2025: $82.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $242.01 | 2019-2025 | Collagenase Santyl, Regranex, Pico |
| Organogenesis INC. | $168.15 | 2019-2025 | Puraply Am, Puraply Wound Matrix |
| Kci USA, INC. | $45.16 | 2022-2023 | Activ.A.C. Ion Progress |
| Abbvie INC. | $35.27 | 2023-2024 | |
| Urgo Medical North America, LLC | $33.19 | 2024 | Urgoclean Ag |
| Next Science LLC | $32.55 | 2023 | Surgx, Xperience, Blastx |
| Argenx US, INC. | $23.57 | 2025 | Vyvgart Hytrulo, Vyvgart |
| Hartmann USA, INC. | $13.81 | 2025 | Zetuvit Plus 10x10 P10 |
| La Jolla Pharmaceutical Company | $13.17 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.04 | 2022 | |
| Portola Pharmaceuticals, LLC | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Mayeaux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.